DG
Daniil Gataulin Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
68
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $11 |
102%
upside
| 1 | +40% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $31 |
70%
upside
| 2 | +16% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $7 |
274%
upside
| 2 | +24% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $15 |
286%
upside
| 1 | -11% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $29 |
92%
upside
| 1 | +40% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $1 |
174%
upside
| 2 | – |
–
| 18 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $21 |
122%
upside
| 1 | -0.14% |
0
%
| 18 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $50 |
427%
upside
| 2 | +1.7% |
0
%
| 10 Feb ‘26 2 months ago |
|